S&P 500   3,621.63 (-0.46%)
DOW   29,638.64 (-0.91%)
QQQ   299.62 (+0.20%)
AAPL   119.05 (+2.11%)
MSFT   214.07 (-0.54%)
FB   276.97 (-0.30%)
GOOGL   1,754.40 (-1.83%)
AMZN   3,168.04 (-0.85%)
TSLA   567.60 (-3.10%)
NVDA   536.06 (+1.06%)
BABA   263.36 (-4.75%)
CGC   28.80 (-0.69%)
GE   10.18 (-2.12%)
MU   64.09 (-0.22%)
AMD   92.66 (+6.27%)
T   28.75 (-0.96%)
NIO   50.53 (-6.43%)
F   9.08 (-0.11%)
ACB   11.68 (+11.56%)
NFLX   490.70 (-0.13%)
BA   210.71 (-2.67%)
GILD   60.67 (+1.07%)
DIS   148.01 (+0.60%)
S&P 500   3,621.63 (-0.46%)
DOW   29,638.64 (-0.91%)
QQQ   299.62 (+0.20%)
AAPL   119.05 (+2.11%)
MSFT   214.07 (-0.54%)
FB   276.97 (-0.30%)
GOOGL   1,754.40 (-1.83%)
AMZN   3,168.04 (-0.85%)
TSLA   567.60 (-3.10%)
NVDA   536.06 (+1.06%)
BABA   263.36 (-4.75%)
CGC   28.80 (-0.69%)
GE   10.18 (-2.12%)
MU   64.09 (-0.22%)
AMD   92.66 (+6.27%)
T   28.75 (-0.96%)
NIO   50.53 (-6.43%)
F   9.08 (-0.11%)
ACB   11.68 (+11.56%)
NFLX   490.70 (-0.13%)
BA   210.71 (-2.67%)
GILD   60.67 (+1.07%)
DIS   148.01 (+0.60%)
S&P 500   3,621.63 (-0.46%)
DOW   29,638.64 (-0.91%)
QQQ   299.62 (+0.20%)
AAPL   119.05 (+2.11%)
MSFT   214.07 (-0.54%)
FB   276.97 (-0.30%)
GOOGL   1,754.40 (-1.83%)
AMZN   3,168.04 (-0.85%)
TSLA   567.60 (-3.10%)
NVDA   536.06 (+1.06%)
BABA   263.36 (-4.75%)
CGC   28.80 (-0.69%)
GE   10.18 (-2.12%)
MU   64.09 (-0.22%)
AMD   92.66 (+6.27%)
T   28.75 (-0.96%)
NIO   50.53 (-6.43%)
F   9.08 (-0.11%)
ACB   11.68 (+11.56%)
NFLX   490.70 (-0.13%)
BA   210.71 (-2.67%)
GILD   60.67 (+1.07%)
DIS   148.01 (+0.60%)
S&P 500   3,621.63 (-0.46%)
DOW   29,638.64 (-0.91%)
QQQ   299.62 (+0.20%)
AAPL   119.05 (+2.11%)
MSFT   214.07 (-0.54%)
FB   276.97 (-0.30%)
GOOGL   1,754.40 (-1.83%)
AMZN   3,168.04 (-0.85%)
TSLA   567.60 (-3.10%)
NVDA   536.06 (+1.06%)
BABA   263.36 (-4.75%)
CGC   28.80 (-0.69%)
GE   10.18 (-2.12%)
MU   64.09 (-0.22%)
AMD   92.66 (+6.27%)
T   28.75 (-0.96%)
NIO   50.53 (-6.43%)
F   9.08 (-0.11%)
ACB   11.68 (+11.56%)
NFLX   490.70 (-0.13%)
BA   210.71 (-2.67%)
GILD   60.67 (+1.07%)
DIS   148.01 (+0.60%)
Log in
ASX:AC8

AusCann Group Holdings Ltd (AC8.AX) Stock Forecast, Price & News

Add
Compare
Today's Range N/A
50-Day Range
A$0.17
MA: A$0.17
A$0.17
52-Week Range N/A
Volume537,446 shs
Average VolumeN/A
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A
BetaN/A
AusCann Group Holdings Ltd, a pharmaceutical company, researches, develops, cultivates, produces, and distributes cannabinoid-based pharmaceuticals in Australia and internationally. It offers hard-shell capsules using Neuvis technology for the treatment of chronic neuropathic pain. The company is based in West Perth, Australia.

Beat the Market (BTM) Rank

Analyst Opinion: 0.0Community Rank: 2.1Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

0.42 out of 5 stars


Industry, Sector and Symbol

Industry Drug Manufacturers - Specialty & Generic
Sub-IndustryN/A
SectorMedical
CUSIPN/A
CIKN/A
Phone61 0 9561 8834
EmployeesN/A

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$1.21 million
Book ValueA$0.11 per share

Profitability

Miscellaneous

Next Earnings DateN/A
OptionableNot Optionable

Receive AC8 News and Ratings via Email

Sign-up to receive the latest news and ratings for AC8 and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











AusCann Group Holdings Ltd (AC8.AX) (ASX:AC8) Frequently Asked Questions

What stocks does MarketBeat like better than AusCann Group Holdings Ltd (AC8.AX)?

Wall Street analysts have given AusCann Group Holdings Ltd (AC8.AX) a "N/A" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's winning trading ideas this year have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but AusCann Group Holdings Ltd (AC8.AX) wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

Who are some of AusCann Group Holdings Ltd (AC8.AX)'s key competitors?

What other stocks do shareholders of AusCann Group Holdings Ltd (AC8.AX) own?

Who are AusCann Group Holdings Ltd (AC8.AX)'s key executives?

AusCann Group Holdings Ltd (AC8.AX)'s management team includes the following people:
  • Mr. Nicholas Woolf, Chief Exec. Officer (Age 52)
  • Mr. Quentin Heath Megson A.C.A., B.Com., CFO & Joint Company Sec. (Age 49)
  • Ms. Sheena Emslie, Chief Operating Officer
  • Dr. Marc Russo, Chief Medical Advisor
  • Ms. Susan Patricia Hunter A.C.A., B.Com., BCom, F Fin, ACA, AGIA, FFin, GAIC, Joint Company Sec. (Age 45)

What is AusCann Group Holdings Ltd (AC8.AX)'s stock symbol?

AusCann Group Holdings Ltd (AC8.AX) trades on the ASX under the ticker symbol "AC8."

How big of a company is AusCann Group Holdings Ltd (AC8.AX)?

AusCann Group Holdings Ltd (AC8.AX) has a market capitalization of $0.00 and generates $1.21 million in revenue each year.

What is AusCann Group Holdings Ltd (AC8.AX)'s official website?

The official website for AusCann Group Holdings Ltd (AC8.AX) is www.auscann.com.au.

How can I contact AusCann Group Holdings Ltd (AC8.AX)?

The company can be reached via phone at 61 0 9561 8834.

This page was last updated on 11/30/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.